Combined Mutations in Pre‐S/Surface and Core Promoter/Precore Regions of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma: A Case-Control Study
Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Sheng‐Nan Lu(Kaohsiung Chang Gung Memorial Hospital), Jyh‐Chwan Wang(Chang Gung University), Chuan‐Mo Lee(Kaohsiung Chang Gung Memorial Hospital), Tsung‐Hui Hu(National Sun Yat-sen University), Chi‐Sin Changchien(Kaohsiung Chang Gung Memorial Hospital), Chao‐Hung Hung(Kaohsiung Chang Gung Memorial Hospital), Jing‐Houng Wang(Kaohsiung Chang Gung Memorial Hospital)
Cited by 106
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|Gastroenterology|2008|547
Hepatogastroenterology
|Hepatogastroenterology|2012|536